胰腺癌细胞抵抗吉西他滨诱导的细胞死亡的机制研究

《胰腺癌细胞抵抗吉西他滨诱导的细胞死亡的机制研究》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。

1、分类号UDC密级公开胰腺癌细胞抵抗吉西他滨诱导的细胞死亡的机制研究周英慧培养类别全日制学位类型学术学位一级学科(专业类)生物学二级学科(专业)细胞生物学研究方向肿瘤细胞生物学指导教师陈志南教授（院士）培养单位基础部细胞生物学教研室二O一五年五月第四军医大学硕士学位论文目录缩略语表···················································································································1中文摘要··································

2、·················································································3ABSTRACT···············································································································5前言··························································································

3、·························8文献回顾··················································································································10正文··················································································································18第一部分RIP3表达水平与胰腺癌病人生存分析········

4、·····················································181材料···············································································································181.1组织样本数据···········································································································182方法··

5、·············································································································182.1胰腺癌病人生存分析··································································································183结果····································································

6、···········································183.1RIP3的表达与患者总体生存时间显著相关。···································································184讨论···············································································································20第二部分胰腺癌细胞筛选及死亡方式检测······················

7、··············································221材料···············································································································221.1细胞系··································································